{"product_id":"ada-85th-scientific-sessions","title":"ADA 85th Scientific Sessions (Videos + Audios)","description":"\u003cstrong\u003e+ Information:\u003c\/strong\u003e\n\u003cbr\u003e\u003cp data-end=\"376\" data-start=\"235\"\u003e\u003cstrong data-end=\"300\" data-start=\"235\"\u003eADA 85th Scientific Sessions   2025\u003c\/strong\u003e\u003cbr\u003e\u003cstrong data-end=\"376\" data-start=\"303\"\u003eThe World’s Premier Conference on Diabetes Science, Care \u0026amp; Innovation\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-end=\"661\" data-start=\"378\"\u003eJoin thousands of global diabetes professionals at the ADA’s flagship Scientific Sessions, scheduled \u003cstrong data-end=\"499\" data-start=\"479\"\u003eJune 20–23, 2025\u003c\/strong\u003e in \u003cstrong data-end=\"518\" data-start=\"503\"\u003eChicago, IL\u003c\/strong\u003e, with on-demand access available until August 25. This milestone \u003cstrong data-end=\"600\" data-start=\"584\"\u003e85th edition\u003c\/strong\u003e highlights major breakthroughs in diabetes and obesity care.\u003c\/p\u003e\n\u003chr data-end=\"666\" data-start=\"663\"\u003e\n\u003cp data-end=\"688\" data-start=\"668\"\u003e\u003cstrong data-end=\"688\" data-start=\"668\"\u003eWhat You’ll Gain\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-end=\"1362\" data-start=\"690\"\u003e\n\u003cli data-end=\"870\" data-start=\"690\"\u003e\n\u003cp data-end=\"870\" data-start=\"692\"\u003eAccess to \u003cstrong data-end=\"724\" data-start=\"702\"\u003e200+ live sessions\u003c\/strong\u003e, including symposia, panel discussions, debates, poster presentations, and “Ask the Expert” formats—covering basic science to clinical practice\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1090\" data-start=\"871\"\u003e\n\u003cp data-end=\"1090\" data-start=\"873\"\u003eCutting-edge content in \u003cstrong data-end=\"924\" data-start=\"897\"\u003eGLP‑1 and GIP therapies\u003c\/strong\u003e, \u003cstrong data-end=\"952\" data-start=\"926\"\u003ebeta cell regeneration\u003c\/strong\u003e, \u003cstrong data-end=\"977\" data-start=\"954\"\u003ediabetes technology\u003c\/strong\u003e, \u003cstrong data-end=\"1011\" data-start=\"979\"\u003eobesity and metabolic health\u003c\/strong\u003e, \u003cstrong data-end=\"1047\" data-start=\"1013\"\u003ecardiovascular risk management\u003c\/strong\u003e, and \u003cstrong data-end=\"1088\" data-start=\"1053\"\u003ematernal and pediatric diabetes\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1258\" data-start=\"1091\"\u003e\n\u003cp data-end=\"1258\" data-start=\"1093\"\u003eInnovative sessions on \u003cstrong data-end=\"1143\" data-start=\"1116\"\u003eAI, predictive modeling\u003c\/strong\u003e, data-driven analytics, and the ADA Innovation Challenge showcasing emerging startups transforming diabetes care\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1362\" data-start=\"1259\"\u003e\n\u003cp data-end=\"1362\" data-start=\"1261\"\u003ePatient-impact stories and advocacy insights—featuring high-profile speakers and diabetes ambassadors\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"1367\" data-start=\"1364\"\u003e\n\u003cp data-end=\"1390\" data-start=\"1369\"\u003e\u003cstrong data-end=\"1390\" data-start=\"1369\"\u003eWho Should Attend\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-end=\"2025\" data-start=\"1392\"\u003e\n\u003cli data-end=\"1501\" data-start=\"1392\"\u003e\n\u003cp data-end=\"1501\" data-start=\"1394\"\u003e\u003cstrong data-end=\"1439\" data-start=\"1394\"\u003eEndocrinologists and diabetes specialists\u003c\/strong\u003e seeking the latest research and guidelines for patient care\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1632\" data-start=\"1502\"\u003e\n\u003cp data-end=\"1632\" data-start=\"1504\"\u003e\u003cstrong data-end=\"1568\" data-start=\"1504\"\u003ePrimary care physicians, internists, and nurse practitioners\u003c\/strong\u003e managing diabetes and metabolic disorders in general practice\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1769\" data-start=\"1633\"\u003e\n\u003cp data-end=\"1769\" data-start=\"1635\"\u003e\u003cstrong data-end=\"1725\" data-start=\"1635\"\u003eCertified diabetes educators, dietitians, pharmacists, and allied health professionals\u003c\/strong\u003e involved in comprehensive team-based care\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1909\" data-start=\"1770\"\u003e\n\u003cp data-end=\"1909\" data-start=\"1772\"\u003e\u003cstrong data-end=\"1815\" data-start=\"1772\"\u003eResearchers, scientists, and innovators\u003c\/strong\u003e presenting or exploring new ideas in diabetes technology, therapeutics, and systems of care\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2025\" data-start=\"1910\"\u003e\n\u003cp data-end=\"2025\" data-start=\"1912\"\u003e\u003cstrong data-end=\"1956\" data-start=\"1912\"\u003eMedical residents, fellows, and trainees\u003c\/strong\u003e building a foundation in diabetes management and emerging treatments\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"2030\" data-start=\"2027\"\u003e\n\u003cp data-end=\"2061\" data-start=\"2032\"\u003e\u003cstrong data-end=\"2061\" data-start=\"2032\"\u003eWhy This Event Stands Out\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-end=\"2563\" data-start=\"2063\"\u003e\n\u003cli data-end=\"2194\" data-start=\"2063\"\u003e\n\u003cp data-end=\"2194\" data-start=\"2065\"\u003eCelebrating \u003cstrong data-end=\"2104\" data-start=\"2077\"\u003e85 years of ADA history\u003c\/strong\u003e, this Scientific Sessions represents the largest annual diabetes gathering in the world\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2322\" data-start=\"2195\"\u003e\n\u003cp data-end=\"2322\" data-start=\"2197\"\u003eComprehensive multidisciplinary format—from cutting-edge research to patient storytelling and hands-on technology showcases\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2444\" data-start=\"2323\"\u003e\n\u003cp data-end=\"2444\" data-start=\"2325\"\u003eIncludes the \u003cstrong data-end=\"2362\" data-start=\"2338\"\u003eInnovation Challenge\u003c\/strong\u003e, where rising companies propose disruptive ideas and solutions in diabetes care\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2563\" data-start=\"2445\"\u003e\n\u003cp data-end=\"2563\" data-start=\"2447\"\u003eMix of in-person engagement and on-demand access ensures networking, education, and flexibility after the conference\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"2568\" data-start=\"2565\"\u003e\n\u003cp data-end=\"2601\" data-start=\"2570\"\u003e\u003cstrong data-end=\"2601\" data-start=\"2570\"\u003eStay Ahead in Diabetes Care\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-end=\"2797\" data-start=\"2603\"\u003eExperience the \u003cstrong data-end=\"2652\" data-start=\"2618\"\u003eADA’s 85th Scientific Sessions\u003c\/strong\u003e to integrate emerging science into your clinical practice, collaborate with global experts, and help drive next-generation diabetes innovations.\u003c\/p\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eA Beta Way of Looking at T1D_ Scientific Insights into Beta Cell Function in Type 1 Diabetes.mp3\u003cbr\u003eA Beta Way of Looking at T1D_ Scientific Insights into Beta Cell Function in Type 1 Diabetes.mp4\u003cbr\u003eADA Chief Executive Officer Remarks; President, Health Care \u0026amp; Education Address; and Outstanding Educator in Diabetes Award Lecture.mp3\u003cbr\u003eADA Chief Executive Officer Remarks; President, Health Care \u0026amp; Education Address; and Outstanding Educator in Diabetes Award Lecture.mp4\u003cbr\u003eADA Diabetes Care Symposium-How Do We Fix a Broken Health Care System_.mp3\u003cbr\u003eADA Diabetes Care Symposium-How Do We Fix a Broken Health Care System_.mp4\u003cbr\u003eADA Diabetes Journal Symposium-Shifting from Quantity to Quality.mp3\u003cbr\u003eADA Diabetes Journal Symposium-Shifting from Quantity to Quality.mp4\u003cbr\u003eADA Education Recognition Program (ERP)-Learning to Unlearn to Learn to Drive Innovation in Population Health Delivery, What We Know About ..mp3\u003cbr\u003eADA Education Recognition Program (ERP)-Learning to Unlearn to Learn to Drive Innovation in Population Health Delivery, What We Know About ..mp4\u003cbr\u003eADA Scholars 1.mp3\u003cbr\u003eADA Scholars 1.mp4\u003cbr\u003eADA Scholars 2.mp3\u003cbr\u003eADA Scholars 2.mp4\u003cbr\u003eADA Symposium-Major Advances and Discoveries in Diabetes-Year in Review.mp3\u003cbr\u003eADA Symposium-Major Advances and Discoveries in Diabetes-Year in Review.mp4\u003cbr\u003eAdaptation of Diabetes Technologies.mp3\u003cbr\u003eAdaptation of Diabetes Technologies.mp4\u003cbr\u003eAddressing the Residual Cardiovascular Risk in People with Diabetes and ASCVD.mp3\u003cbr\u003eAddressing the Residual Cardiovascular Risk in People with Diabetes and ASCVD.mp4\u003cbr\u003eADJUnct Semaglutide Treatment in Type 1 Diabetes (ADJUST-T1D) Trial Outcomes.mp3\u003cbr\u003eADJUnct Semaglutide Treatment in Type 1 Diabetes (ADJUST-T1D) Trial Outcomes.mp4\u003cbr\u003eAdjunctive Therapies to Prevent Complications in Type 1 Diabetes.mp3\u003cbr\u003eAdjunctive Therapies to Prevent Complications in Type 1 Diabetes.mp4\u003cbr\u003eAdvances and Trends in Diabetes Technology.mp3\u003cbr\u003eAdvances and Trends in Diabetes Technology.mp4\u003cbr\u003eAdvances in Neuronal and Adipose Contributors to Body Weight Maintenance.mp3\u003cbr\u003eAdvances in Neuronal and Adipose Contributors to Body Weight Maintenance.mp4\u003cbr\u003eAdvancing and Facilitating Basal Insulin Therapy in Type 2 Diabetes-Breaking News on the QWINT 1, 3, and 4 Trials with Once-Weekly Insulin ..mp3\u003cbr\u003eAdvancing and Facilitating Basal Insulin Therapy in Type 2 Diabetes-Breaking News on the QWINT 1, 3, and 4 Trials with Once-Weekly Insulin ..mp4\u003cbr\u003eAdvancing Care for Diabetic Kidney Disease-Top Research Abstracts.mp3\u003cbr\u003eAdvancing Care for Diabetic Kidney Disease-Top Research Abstracts.mp4\u003cbr\u003eAdvancing Diabetes Care through Technology-Insights from CGM Systems, Automated Insulin Delivery, and Digital Engagement (With Richard R. R..mp3\u003cbr\u003eAdvancing Diabetes Care through Technology-Insights from CGM Systems, Automated Insulin Delivery, and Digital Engagement (With Richard R. R..mp4\u003cbr\u003eAdvancing Diabetic Retinopathy Care-Integrating Clinical Insights, AI, and Health Equity.mp3\u003cbr\u003eAdvancing Diabetic Retinopathy Care-Integrating Clinical Insights, AI, and Health Equity.mp4\u003cbr\u003eAdvancing Effective and Equitable Treatment of Hyperglycemia in Pregnancy (With Norbert Freinkel Award Lecture).mp3\u003cbr\u003eAdvancing Effective and Equitable Treatment of Hyperglycemia in Pregnancy (With Norbert Freinkel Award Lecture).mp4\u003cbr\u003eAdvancing Hyperglycemia Management in Endogenous Hypercortisolism_ Applying CATALYST Data to Clinical Practice.mp3\u003cbr\u003eAdvancing Hyperglycemia Management in Endogenous Hypercortisolism_ Applying CATALYST Data to Clinical Practice.mp4\u003cbr\u003eAdvancing Our Understanding of Inflammation and Autoimmunity-Insights from Animal Models.mp3\u003cbr\u003eAdvancing Our Understanding of Inflammation and Autoimmunity-Insights from Animal Models.mp4\u003cbr\u003eAging and Thriving-Diabetes, Cognition, and Older Adults.mp3\u003cbr\u003eAging and Thriving-Diabetes, Cognition, and Older Adults.mp4\u003cbr\u003eApoptosis (Living, Dying, and Surviving in the Pancreatic Islet).mp3\u003cbr\u003eApoptosis (Living, Dying, and Surviving in the Pancreatic Islet).mp4\u003cbr\u003eBench to Bedside and Beyond-Bioengineering in Beta-Cell Replacement Therapy.mp3\u003cbr\u003eBench to Bedside and Beyond-Bioengineering in Beta-Cell Replacement Therapy.mp4\u003cbr\u003eBeta-Cell Development and Postnatal Growth-The Ever-Changing Pancreatic Islet.mp3\u003cbr\u003eBeta-Cell Development and Postnatal Growth-The Ever-Changing Pancreatic Islet.mp4\u003cbr\u003eBeta-Cell Stimulus-Secretion Coupling and Metabolism-Novel Pathways Affecting Islet Hormone Secretion.mp3\u003cbr\u003eBeta-Cell Stimulus-Secretion Coupling and Metabolism-Novel Pathways Affecting Islet Hormone Secretion.mp4\u003cbr\u003eBridging the Gap-The Brain-Peripheral Nervous System Connection in Diabetes.mp3\u003cbr\u003eBridging the Gap-The Brain-Peripheral Nervous System Connection in Diabetes.mp4\u003cbr\u003eCan We Improve the Quality of Weight Loss by Augmenting Fat Mass Loss while Preserving Lean Mass_ The BELIEVE Study of Bimagrumab + Semaglu..mp3\u003cbr\u003eCan We Improve the Quality of Weight Loss by Augmenting Fat Mass Loss while Preserving Lean Mass_ The BELIEVE Study of Bimagrumab + Semaglu..mp4\u003cbr\u003eCardiovascular Complications of Long Term Diabetes-Type 1 vs. Type 2.mp3\u003cbr\u003eCardiovascular Complications of Long Term Diabetes-Type 1 vs. Type 2.mp4\u003cbr\u003eCelebrating NIDDK’s 75th Anniversary-Clinical, Translational and Basic Advances, Current Research Priorities and Future Direction.mp3\u003cbr\u003eCelebrating NIDDK’s 75th Anniversary-Clinical, Translational and Basic Advances, Current Research Priorities and Future Direction.mp4\u003cbr\u003eCellular Mechanisms of Atherogenesis in Diabetes (With Edwin Bierman Award Lecture).mp3\u003cbr\u003eCellular Mechanisms of Atherogenesis in Diabetes (With Edwin Bierman Award Lecture).mp4\u003cbr\u003eCentral Regulation of Hunger Signal and Body Weight Homeostasis.mp3\u003cbr\u003eCentral Regulation of Hunger Signal and Body Weight Homeostasis.mp4\u003cbr\u003eCGM in Action-Smarter Choices, Better Balance, Lasting Impact.mp3\u003cbr\u003eCGM in Action-Smarter Choices, Better Balance, Lasting Impact.mp4\u003cbr\u003eClinical Applications of Artificial Intelligence and Diabetes Technology.mp3\u003cbr\u003eClinical Applications of Artificial Intelligence and Diabetes Technology.mp4\u003cbr\u003eClinical Deep Dive_ Unlocking the Treatment Potential of Rezdiffra.mp3\u003cbr\u003eClinical Deep Dive_ Unlocking the Treatment Potential of Rezdiffra.mp4\u003cbr\u003eClosing the Critical Care Gap_ Making Hypoglycemia Readiness Routine.mp3\u003cbr\u003eClosing the Critical Care Gap_ Making Hypoglycemia Readiness Routine.mp4\u003cbr\u003eConsensus or Controversy_ Hot Topics in Nutrition 2025.mp3\u003cbr\u003eConsensus or Controversy_ Hot Topics in Nutrition 2025.mp4\u003cbr\u003eContinuous Ketone Monitoring-Innovations and Clinical Applications.mp3\u003cbr\u003eContinuous Ketone Monitoring-Innovations and Clinical Applications.mp4\u003cbr\u003eControl-IQ+ Technology_ Advancing Patient-Centered Insulin Therapy Across Type 2, Pediatrics, and Varying Insulin Needs.mp3\u003cbr\u003eControl-IQ+ Technology_ Advancing Patient-Centered Insulin Therapy Across Type 2, Pediatrics, and Varying Insulin Needs.mp4\u003cbr\u003eControversies in Continuous Glucose Monitoring.mp3\u003cbr\u003eControversies in Continuous Glucose Monitoring.mp4\u003cbr\u003eControversies in Peripartum Management of Diabetes.mp3\u003cbr\u003eControversies in Peripartum Management of Diabetes.mp4\u003cbr\u003eCross-Sectoral Platforms-Transforming Diabetes Prevention for All.mp3\u003cbr\u003eCross-Sectoral Platforms-Transforming Diabetes Prevention for All.mp4\u003cbr\u003eDecoding Alpha- and Beta-Cell Function-Human Studies Advancing Imaging, Biomarkers, and Therapeutic Insights.mp3\u003cbr\u003eDecoding Alpha- and Beta-Cell Function-Human Studies Advancing Imaging, Biomarkers, and Therapeutic Insights.mp4\u003cbr\u003eDecoding Diabetes-AI-Driven Advances in Genetic Research.mp3\u003cbr\u003eDecoding Diabetes-AI-Driven Advances in Genetic Research.mp4\u003cbr\u003eDecoding Type 1 Diabetes-Lessons from Trials and Deep Data Dives.mp3\u003cbr\u003eDecoding Type 1 Diabetes-Lessons from Trials and Deep Data Dives.mp4\u003cbr\u003eDiabetes and Heart Talk.mp3\u003cbr\u003eDiabetes and Heart Talk.mp4\u003cbr\u003eDiabetes and Peripheral Artery Disease-Evolving Role of GLP-1 RA and New Insights from the STRIDE Trial.mp3\u003cbr\u003eDiabetes and Peripheral Artery Disease-Evolving Role of GLP-1 RA and New Insights from the STRIDE Trial.mp4\u003cbr\u003eDiabetes Care Deadlock-Integrating Behavioral Health to Overcome Barriers.mp3\u003cbr\u003eDiabetes Care Deadlock-Integrating Behavioral Health to Overcome Barriers.mp4\u003cbr\u003eDiabetes Care-Let’s Pick Up the Pace-Addressing Inequities in Diabetes Care.mp3\u003cbr\u003eDiabetes Care-Let’s Pick Up the Pace-Addressing Inequities in Diabetes Care.mp4\u003cbr\u003eDiabetes in Children-Pediatric Type 1 Diabetes-Decoding the Disease and Transforming Care.mp3\u003cbr\u003eDiabetes in Children-Pediatric Type 1 Diabetes-Decoding the Disease and Transforming Care.mp4\u003cbr\u003eDiabetic Neuropathy-Unraveling Pain Mechanisms, Systemic Complications, and Innovations in Prevention and Treatmentÿ(With ADA Presidents’ S..mp3\u003cbr\u003eDiabetic Neuropathy-Unraveling Pain Mechanisms, Systemic Complications, and Innovations in Prevention and Treatmentÿ(With ADA Presidents’ S..mp4\u003cbr\u003eDigital Diabetes Education-AI, Social Media, and Innovative Learning for Better Outcomes.mp3\u003cbr\u003eDigital Diabetes Education-AI, Social Media, and Innovative Learning for Better Outcomes.mp4\u003cbr\u003eDiscussion on Behavioral Medicine and Psychology-ABC’s of AI to Support Health Behaviors and Mental Health in Diabetes Care.mp3\u003cbr\u003eDiscussion on Behavioral Medicine and Psychology-ABC’s of AI to Support Health Behaviors and Mental Health in Diabetes Care.mp4\u003cbr\u003eDiscussion on Clinical Centers and Programs-Strengthening the Diabetes Workforce through Training and Certification Opportunities.mp3\u003cbr\u003eDiscussion on Clinical Centers and Programs-Strengthening the Diabetes Workforce through Training and Certification Opportunities.mp4\u003cbr\u003eDiscussion on Diabetes and Cardiovascular Disease-Addressing Cardiovascular and Kidney Disease in Type 1 Diabetes-Lessons from Type 2 Diabe..mp3\u003cbr\u003eDiscussion on Diabetes and Cardiovascular Disease-Addressing Cardiovascular and Kidney Disease in Type 1 Diabetes-Lessons from Type 2 Diabe..mp4\u003cbr\u003eDiscussion on Diabetes in Youth-D-Tech and DEB-The Spectrum of Disordered Eating Behaviors in Children, Adolescents, and Young Adults Using..mp3\u003cbr\u003eDiscussion on Diabetes in Youth-D-Tech and DEB-The Spectrum of Disordered Eating Behaviors in Children, Adolescents, and Young Adults Using..mp4\u003cbr\u003eDiscussion on Diabetes Self-Management Education and Support (DSMES)-Innovations for DSMES- Challenges and Solutions.mp3\u003cbr\u003eDiscussion on Diabetes Self-Management Education and Support (DSMES)-Innovations for DSMES- Challenges and Solutions.mp4\u003cbr\u003eDiscussion on Diabetes Technology-Diabetes Technology Distress.mp3\u003cbr\u003eDiscussion on Diabetes Technology-Diabetes Technology Distress.mp4\u003cbr\u003eDiscussion on Exercise Physiology-Lifestyle Interventions and Cognitive Function.mp3\u003cbr\u003eDiscussion on Exercise Physiology-Lifestyle Interventions and Cognitive Function.mp4\u003cbr\u003eDiscussion on Eye Health-Diabetic Retinopathy-AI Solutions for Screening, Follow-Up, and Workflow Integration.mp3\u003cbr\u003eDiscussion on Eye Health-Diabetic Retinopathy-AI Solutions for Screening, Follow-Up, and Workflow Integration.mp4\u003cbr\u003eDiscussion on Foot Care-Innovations in Limb Salvage-Technology and Amputation Prevention.mp3\u003cbr\u003eDiscussion on Foot Care-Innovations in Limb Salvage-Technology and Amputation Prevention.mp4\u003cbr\u003eDiscussion on Health Care Delivery and Quality Improvement-AI and Machine Learning in Diabetes Management.mp3\u003cbr\u003eDiscussion on Health Care Delivery and Quality Improvement-AI and Machine Learning in Diabetes Management.mp4\u003cbr\u003eDiscussion on Immunology and Beta-Cell Replacement-Unraveling the Immunological Puzzle of Type 1 Diabetes-The Converging Roles of T Cells, ..mp3\u003cbr\u003eDiscussion on Immunology and Beta-Cell Replacement-Unraveling the Immunological Puzzle of Type 1 Diabetes-The Converging Roles of T Cells, ..mp4\u003cbr\u003eDiscussion on Islet Biology, Development, and Function-That Which Does Not Kill You-The Resilient Beta Cell.mp3\u003cbr\u003eDiscussion on Islet Biology, Development, and Function-That Which Does Not Kill You-The Resilient Beta Cell.mp4\u003cbr\u003eDiscussion on Nutritional Science and Metabolism-Climate Change, Nutrition, and Diabetes.mp3\u003cbr\u003eDiscussion on Nutritional Science and Metabolism-Climate Change, Nutrition, and Diabetes.mp4\u003cbr\u003eDiscussion on Pregnancy and Reproductive Health-Early Postpartum GDM Screening.mp3\u003cbr\u003eDiscussion on Pregnancy and Reproductive Health-Early Postpartum GDM Screening.mp4\u003cbr\u003eDiscussion on Primary Care-Making the Diagnosis (Did I See a Zebra_).mp3\u003cbr\u003eDiscussion on Primary Care-Making the Diagnosis (Did I See a Zebra_).mp4\u003cbr\u003eDiscussion on Public Health and Epidemiology-Diabetes Prevention Across Ages and Settings.mp3\u003cbr\u003eDiscussion on Public Health and Epidemiology-Diabetes Prevention Across Ages and Settings.mp4\u003cbr\u003eDiscussion on Women’s Interprofessional Network of the ADA (WIN ADA)-Sponsoring Women in Diabetes Professions.mp3\u003cbr\u003eDiscussion on Women’s Interprofessional Network of the ADA (WIN ADA)-Sponsoring Women in Diabetes Professions.mp4\u003cbr\u003eDiverse Antigens Targeted in Type 1 Diabetes.mp3\u003cbr\u003eDiverse Antigens Targeted in Type 1 Diabetes.mp4\u003cbr\u003eEarly Phase, Post Hoc, and Subgroup Analyses from Clinical Trials Testing Incretin-Based Therapies-Take 1.mp3\u003cbr\u003eEarly Phase, Post Hoc, and Subgroup Analyses from Clinical Trials Testing Incretin-Based Therapies-Take 1.mp4\u003cbr\u003eEarly Phase, Post Hoc, and Subgroup Analyses from Clinical Trials with Incretin-Based Therapies-Take 2.mp3\u003cbr\u003eEarly Phase, Post Hoc, and Subgroup Analyses from Clinical Trials with Incretin-Based Therapies-Take 2.mp4\u003cbr\u003eEfficacy and Safety of CagriSema 2.4mg_2.4mg in Adults with Overweight_Obesity-The REDEFINE 1 and REDEFINE 2 Clinical Trials.mp3\u003cbr\u003eEfficacy and Safety of CagriSema 2.4mg_2.4mg in Adults with Overweight_Obesity-The REDEFINE 1 and REDEFINE 2 Clinical Trials.mp4\u003cbr\u003eEmerging Biomarkers and Trajectories of ASCVD Risk Progressionÿ(With ADA Presidents’ Select Abstract Presentation).mp3\u003cbr\u003eEmerging Biomarkers and Trajectories of ASCVD Risk Progressionÿ(With ADA Presidents’ Select Abstract Presentation).mp4\u003cbr\u003eEmerging Mechanisms, Risk Factors, and Cellular Insights in Diabetic Neuropathy and Cognitive Impairment.mp3\u003cbr\u003eEmerging Mechanisms, Risk Factors, and Cellular Insights in Diabetic Neuropathy and Cognitive Impairment.mp4\u003cbr\u003eEmerging Non-Peptide, Small Molecule GLP-1 Receptor Agonists-Can They Become Players_.mp3\u003cbr\u003eEmerging Non-Peptide, Small Molecule GLP-1 Receptor Agonists-Can They Become Players_.mp4\u003cbr\u003eEmpowering Choice-Nutrition Interventions for Type 2 Diabetes.mp3\u003cbr\u003eEmpowering Choice-Nutrition Interventions for Type 2 Diabetes.mp4\u003cbr\u003eEmpowering Health Outcomes Utilizing Glooko’s Data Integration.mp3\u003cbr\u003eEmpowering Health Outcomes Utilizing Glooko’s Data Integration.mp4\u003cbr\u003eEmpowering Personalized Diabetes Care, the Next Frontier of Sensing Technology.mp3\u003cbr\u003eEmpowering Personalized Diabetes Care, the Next Frontier of Sensing Technology.mp4\u003cbr\u003eEncapsulation vs. Naked Cell Therapy-Immune Challenges and Beta-Cell Perspectives in Diabetes Treatment.mp3\u003cbr\u003eEncapsulation vs. Naked Cell Therapy-Immune Challenges and Beta-Cell Perspectives in Diabetes Treatment.mp4\u003cbr\u003eEverything You Want to Know about the Latest Advances in Pediatric Type 2 Diabetes.mp3\u003cbr\u003eEverything You Want to Know about the Latest Advances in Pediatric Type 2 Diabetes.mp4\u003cbr\u003eExercise Types-Mechanisms of Actions and Modeling Effects.mp3\u003cbr\u003eExercise Types-Mechanisms of Actions and Modeling Effects.mp4\u003cbr\u003eExerciseRx-Still Relevant for Diabetes in the Modern Age of Pharmacotherapy_.mp3\u003cbr\u003eExerciseRx-Still Relevant for Diabetes in the Modern Age of Pharmacotherapy_.mp4\u003cbr\u003eExpanding Obesity Therapeutic Options-Preclinical Studies.mp3\u003cbr\u003eExpanding Obesity Therapeutic Options-Preclinical Studies.mp4\u003cbr\u003eExpanding the Dexcom Portfolio_ÿ Introducing the most accurate1,2 and longest lasting CGM_+,1.mp3\u003cbr\u003eExpanding the Dexcom Portfolio_ÿ Introducing the most accurate1,2 and longest lasting CGM_+,1.mp4\u003cbr\u003eExperimental and Multiomic Approaches to Decipher Mechanism of Type 1 and Type 2 Diabetes.mp3\u003cbr\u003eExperimental and Multiomic Approaches to Decipher Mechanism of Type 1 and Type 2 Diabetes.mp4\u003cbr\u003eExploring Alternative Strategies to Stem Cell-Derived Beta Cells and Insights from Autologous Islet Transplantation.mp3\u003cbr\u003eExploring Alternative Strategies to Stem Cell-Derived Beta Cells and Insights from Autologous Islet Transplantation.mp4\u003cbr\u003eFactors Affecting the Molecular Architecture and Identity of Islet Cells.mp3\u003cbr\u003eFactors Affecting the Molecular Architecture and Identity of Islet Cells.mp4\u003cbr\u003eFamily Dynamics and Psychosocial Interventions in Youth with Type 1 Diabetes-Addressing Health Disparities and Enhancing Outcomes.mp3\u003cbr\u003eFamily Dynamics and Psychosocial Interventions in Youth with Type 1 Diabetes-Addressing Health Disparities and Enhancing Outcomes.mp4\u003cbr\u003eFood Is Medicine_-Is It a Solution or a Convenient Fix to a Complicated Problem.mp3\u003cbr\u003eFood Is Medicine_-Is It a Solution or a Convenient Fix to a Complicated Problem.mp4\u003cbr\u003eFrom Bench to Big Data-Integrating Human Data and Animal Models to Improve Diabetic Foot Outcomes.mp3\u003cbr\u003eFrom Bench to Big Data-Integrating Human Data and Animal Models to Improve Diabetic Foot Outcomes.mp4\u003cbr\u003eFrom Glucose Streams to Phenotype Dreams-The Future of Continuous Monitoring.mp3\u003cbr\u003eFrom Glucose Streams to Phenotype Dreams-The Future of Continuous Monitoring.mp4\u003cbr\u003eFrom Screening, Telemonitoring, to Care Coordination-Improving Quality.mp3\u003cbr\u003eFrom Screening, Telemonitoring, to Care Coordination-Improving Quality.mp4\u003cbr\u003eFueling the Body-The Complex Interplay of Sugar, Fat, and Protein.mp3\u003cbr\u003eFueling the Body-The Complex Interplay of Sugar, Fat, and Protein.mp4\u003cbr\u003eFuture Ready-Breakthroughs in Pediatric Type 1 Diabetes Care.mp3\u003cbr\u003eFuture Ready-Breakthroughs in Pediatric Type 1 Diabetes Care.mp4\u003cbr\u003eGenes and Microbes-Old Foes and New Revelations on the Road to Type 1 Diabetes.mp3\u003cbr\u003eGenes and Microbes-Old Foes and New Revelations on the Road to Type 1 Diabetes.mp4\u003cbr\u003eGenetic Regulation of Beta-Cell Mass and Function in Humans-Lessons from GWAS and Rare Genetics.mp3\u003cbr\u003eGenetic Regulation of Beta-Cell Mass and Function in Humans-Lessons from GWAS and Rare Genetics.mp4\u003cbr\u003eGenetics of Type 2 Diabetes-Exploring Risk, Comorbidities, and Treatment Responses.mp3\u003cbr\u003eGenetics of Type 2 Diabetes-Exploring Risk, Comorbidities, and Treatment Responses.mp4\u003cbr\u003eGetting the Career You Envision-How to Negotiate For What You Need (And Want).mp3\u003cbr\u003eGetting the Career You Envision-How to Negotiate For What You Need (And Want).mp4\u003cbr\u003eGlobal Diabetes Guidelines-Bridging Borders for Collaborative Care and Shared Insights.mp3\u003cbr\u003eGlobal Diabetes Guidelines-Bridging Borders for Collaborative Care and Shared Insights.mp4\u003cbr\u003eGLP-1RAs-Miracle Drug or Behavioral Health Minefield_.mp3\u003cbr\u003eGLP-1RAs-Miracle Drug or Behavioral Health Minefield_.mp4\u003cbr\u003eHealth Access Symposium-Community Interventions and Connections.mp3\u003cbr\u003eHealth Access Symposium-Community Interventions and Connections.mp4\u003cbr\u003eHeterogeneity of Diabetes-New Initiatives from NIDDK.mp3\u003cbr\u003eHeterogeneity of Diabetes-New Initiatives from NIDDK.mp4\u003cbr\u003eHiding in Plain Sight-The Need to Address Diabetes Identity in Order to Optimize Outcomes.mp3\u003cbr\u003eHiding in Plain Sight-The Need to Address Diabetes Identity in Order to Optimize Outcomes.mp4\u003cbr\u003eHot Topics in Lipid Management in Diabetes.mp3\u003cbr\u003eHot Topics in Lipid Management in Diabetes.mp4\u003cbr\u003eHow Can We Better Understand Obesity_ An interactive presentation about obesity and liver health.mp3\u003cbr\u003eHow Can We Better Understand Obesity_ An interactive presentation about obesity and liver health.mp4\u003cbr\u003eHow Point of Care Testing Can Change the Trajectory of Managing Diabetes.mp3\u003cbr\u003eHow Point of Care Testing Can Change the Trajectory of Managing Diabetes.mp4\u003cbr\u003eIf You Had to Pick Just One-GLP-1RA, GIP_GLP-1RA or SGLT2i for Type 2 Diabetes_.mp3\u003cbr\u003eIf You Had to Pick Just One-GLP-1RA, GIP_GLP-1RA or SGLT2i for Type 2 Diabetes_.mp4\u003cbr\u003eImpact of Large-Scale Natural Experiments in Diabetes from the NEXT-D3 Research Network.mp3\u003cbr\u003eImpact of Large-Scale Natural Experiments in Diabetes from the NEXT-D3 Research Network.mp4\u003cbr\u003eImplementing Improvements in Care Delivery.mp3\u003cbr\u003eImplementing Improvements in Care Delivery.mp4\u003cbr\u003eImproving Systems of Care for Diabetes Mellitus.mp3\u003cbr\u003eImproving Systems of Care for Diabetes Mellitus.mp4\u003cbr\u003eIncretin-Based Combination Therapies for Obesity-Clinical Studies.mp3\u003cbr\u003eIncretin-Based Combination Therapies for Obesity-Clinical Studies.mp4\u003cbr\u003eInnovating Stem Cell Manufacturing and Engraftment Strategies for Cell Replacement Therapy.mp3\u003cbr\u003eInnovating Stem Cell Manufacturing and Engraftment Strategies for Cell Replacement Therapy.mp4\u003cbr\u003eInnovation and Progress in Stem Cell-Derived Islet-Cell Replacement Therapy.mp3\u003cbr\u003eInnovation and Progress in Stem Cell-Derived Islet-Cell Replacement Therapy.mp4\u003cbr\u003eInnovation Challenge-Note_ Continuing Education Credit Is Not Awarded for this Session.mp3\u003cbr\u003eInnovation Challenge-Note_ Continuing Education Credit Is Not Awarded for this Session.mp4\u003cbr\u003eInnovative Solutions to the Challenges of Inpatient Diabetes Care and Education-From Hospital to Home.mp3\u003cbr\u003eInnovative Solutions to the Challenges of Inpatient Diabetes Care and Education-From Hospital to Home.mp4\u003cbr\u003eInnovative Strategies in Diabetes Management-Integrating Technology, Personalized Interventions, and Community-Based Approaches.mp3\u003cbr\u003eInnovative Strategies in Diabetes Management-Integrating Technology, Personalized Interventions, and Community-Based Approaches.mp4\u003cbr\u003eInsulin Action and Its Systemic Effects.mp3\u003cbr\u003eInsulin Action and Its Systemic Effects.mp4\u003cbr\u003eIntegrating Obesity Pathogenesis into Policy.mp3\u003cbr\u003eIntegrating Obesity Pathogenesis into Policy.mp4\u003cbr\u003eInteroception-Brain-Body Communication Controls Metabolism.mp3\u003cbr\u003eInteroception-Brain-Body Communication Controls Metabolism.mp4\u003cbr\u003eInterventions to Prevent Hypoglycemia-Bench-to-Bedside.mp3\u003cbr\u003eInterventions to Prevent Hypoglycemia-Bench-to-Bedside.mp4\u003cbr\u003eIs There Still a Place for Bariatric Surgery_.mp3\u003cbr\u003eIs There Still a Place for Bariatric Surgery_.mp4\u003cbr\u003eIt’s Complicated-Diabetes Profiles, Pathways, and Problems.mp3\u003cbr\u003eIt’s Complicated-Diabetes Profiles, Pathways, and Problems.mp4\u003cbr\u003eJoint ADA_AACC Symposium-1 Hour Glucose to Diagnose Intermediate Hyperglycemia and Diabetes. Do We Need Another Test_.mp3\u003cbr\u003eJoint ADA_AACC Symposium-1 Hour Glucose to Diagnose Intermediate Hyperglycemia and Diabetes. Do We Need Another Test_.mp4\u003cbr\u003eJoint ADA_IPITA Symposium-Outpacing the Immune System-Sprinting towards Immune Protection for Cell Replacement Therapy.mp3\u003cbr\u003eJoint ADA_IPITA Symposium-Outpacing the Immune System-Sprinting towards Immune Protection for Cell Replacement Therapy.mp4\u003cbr\u003eJoint ADA_ISPAD Symposium-Exploring Emerging Treatments for Pediatric Diabetes.mp3\u003cbr\u003eJoint ADA_ISPAD Symposium-Exploring Emerging Treatments for Pediatric Diabetes.mp4\u003cbr\u003eKelly West Award for Outstanding Achievement in Epidemiology Lecture.mp3\u003cbr\u003eKelly West Award for Outstanding Achievement in Epidemiology Lecture.mp4\u003cbr\u003eLancet Journal Symposium-Early-Onset Type 2 Diabetes.mp3\u003cbr\u003eLancet Journal Symposium-Early-Onset Type 2 Diabetes.mp4\u003cbr\u003eLeveraging Population Diversity to Improve Understanding of the Genetic Etiology of Type 1 and Type 2 Diabetesÿ(With ADA Presidents’ Select..mp3\u003cbr\u003eLeveraging Population Diversity to Improve Understanding of the Genetic Etiology of Type 1 and Type 2 Diabetesÿ(With ADA Presidents’ Select..mp4\u003cbr\u003eLeveraging Technology and Access to Improve Diabetic Foot Care (With Roger Pecoraro Award Lecture).mp3\u003cbr\u003eLeveraging Technology and Access to Improve Diabetic Foot Care (With Roger Pecoraro Award Lecture).mp4\u003cbr\u003eLife with diabetes just got easier.mp3\u003cbr\u003eLife with diabetes just got easier.mp4\u003cbr\u003eLiver at the Crossroads-From Molecules to Mechanisms of Metabolic Healthÿ(With ADA Presidents’ Select Abstract Presentation).mp3\u003cbr\u003eLiver at the Crossroads-From Molecules to Mechanisms of Metabolic Healthÿ(With ADA Presidents’ Select Abstract Presentation).mp4\u003cbr\u003eMaternal and Child Health-Exploring Nutrition, Metabolism, and Genetic Influencesÿ(With ADA Presidents’ Select Abstract Presentation).mp3\u003cbr\u003eMaternal and Child Health-Exploring Nutrition, Metabolism, and Genetic Influencesÿ(With ADA Presidents’ Select Abstract Presentation).mp4\u003cbr\u003eMaximizing Impact-Cost-Effectiveness and Real-World Outcomes of AI-Enabled Diabetic Retinopathy Screening Programs.mp3\u003cbr\u003eMaximizing Impact-Cost-Effectiveness and Real-World Outcomes of AI-Enabled Diabetic Retinopathy Screening Programs.mp4\u003cbr\u003eMechanisms Linking Adipose Health with Lipid and Glucose Homeostasis.mp3\u003cbr\u003eMechanisms Linking Adipose Health with Lipid and Glucose Homeostasis.mp4\u003cbr\u003eMechanistic Insights into Diabetic Kidney Disease-Top Research Abstracts.mp3\u003cbr\u003eMechanistic Insights into Diabetic Kidney Disease-Top Research Abstracts.mp4\u003cbr\u003eMechanistic Insights into Metabolic Dysfunction in the Liver.mp3\u003cbr\u003eMechanistic Insights into Metabolic Dysfunction in the Liver.mp4\u003cbr\u003eMechanistic Insights on Gestational Diabetes and Its Consequencesÿ(With ADA Presidents’ Select Abstract Presentation).mp3\u003cbr\u003eMechanistic Insights on Gestational Diabetes and Its Consequencesÿ(With ADA Presidents’ Select Abstract Presentation).mp4\u003cbr\u003eMedications Effects on the Kidney, Liver, and Epicardium in Diabetes.mp3\u003cbr\u003eMedications Effects on the Kidney, Liver, and Epicardium in Diabetes.mp4\u003cbr\u003eMetabolic and Molecular Characteristics of MASH.mp3\u003cbr\u003eMetabolic and Molecular Characteristics of MASH.mp4\u003cbr\u003eMetabolic Cross Talk and Endocrine Signaling.mp3\u003cbr\u003eMetabolic Cross Talk and Endocrine Signaling.mp4\u003cbr\u003eMetabolic Mediators of Metabolic Wasting.mp3\u003cbr\u003eMetabolic Mediators of Metabolic Wasting.mp4\u003cbr\u003eMetabolic Regulations of Early Worsening and Protection from Diabetic Eye Disease.mp3\u003cbr\u003eMetabolic Regulations of Early Worsening and Protection from Diabetic Eye Disease.mp4\u003cbr\u003eMicrobiota and Immune Interactions in Early Life-Impact on Health and Disease.mp3\u003cbr\u003eMicrobiota and Immune Interactions in Early Life-Impact on Health and Disease.mp4\u003cbr\u003eMolecular and Cellular Mechanisms Driving Muscle Atrophy and Dysfunction.mp3\u003cbr\u003eMolecular and Cellular Mechanisms Driving Muscle Atrophy and Dysfunction.mp4\u003cbr\u003eMolecular and Metabolic Mechanisms in Diabetic Retinopathy.mp3\u003cbr\u003eMolecular and Metabolic Mechanisms in Diabetic Retinopathy.mp4\u003cbr\u003eMolecular Regulation of Muscle Function and Insulin Sensitivity.mp3\u003cbr\u003eMolecular Regulation of Muscle Function and Insulin Sensitivity.mp4\u003cbr\u003eMounjaror (tirzepatide) Product Theater.mp3\u003cbr\u003eMounjaror (tirzepatide) Product Theater.mp4\u003cbr\u003eMuscle and Energy Expenditure-Myths, Legends, and Facts.mp3\u003cbr\u003eMuscle and Energy Expenditure-Myths, Legends, and Facts.mp4\u003cbr\u003eNational Scientific \u0026amp; Health Care Achievement Awards Presentation and Outstanding Scientific Achievement Award Lecture.mp3\u003cbr\u003eNational Scientific \u0026amp; Health Care Achievement Awards Presentation and Outstanding Scientific Achievement Award Lecture.mp4\u003cbr\u003eNeuropathy Potpourri-Unveiling Novel Mechanisms and Urogenital Autonomic Dysfunction Impacts.mp3\u003cbr\u003eNeuropathy Potpourri-Unveiling Novel Mechanisms and Urogenital Autonomic Dysfunction Impacts.mp4\u003cbr\u003eNeurotransmission in the Islet-From Outside to Inside.mp3\u003cbr\u003eNeurotransmission in the Islet-From Outside to Inside.mp4\u003cbr\u003eNew Approaches to Detect and Monitor Diabetes in Pregnancy.mp3\u003cbr\u003eNew Approaches to Detect and Monitor Diabetes in Pregnancy.mp4\u003cbr\u003eNew Molecular Pathways of Thermogenesis.mp3\u003cbr\u003eNew Molecular Pathways of Thermogenesis.mp4\u003cbr\u003eNew Molecular Regulators of Energy Metabolism Independent of Appetite Suppression.mp3\u003cbr\u003eNew Molecular Regulators of Energy Metabolism Independent of Appetite Suppression.mp4\u003cbr\u003eNew Perspectives on Fetal and Placental Responses to Diabetes and Its Treatment.mp3\u003cbr\u003eNew Perspectives on Fetal and Placental Responses to Diabetes and Its Treatment.mp4\u003cbr\u003eNew Technologies to Address Old Questions in Molecular Metabolism.mp3\u003cbr\u003eNew Technologies to Address Old Questions in Molecular Metabolism.mp4\u003cbr\u003eNew-and Surprising-Ways to Lower Glucose in Diabetes.mp3\u003cbr\u003eNew-and Surprising-Ways to Lower Glucose in Diabetes.mp4\u003cbr\u003eNext Generation Therapies for Type 2 Diabetes and Obesity.mp3\u003cbr\u003eNext Generation Therapies for Type 2 Diabetes and Obesity.mp4\u003cbr\u003eNIDDK Early Career Investigator Symposium-Neuroscience and Diabetes-Innovations Across the Translational Science Spectrum.mp3\u003cbr\u003eNIDDK Early Career Investigator Symposium-Neuroscience and Diabetes-Innovations Across the Translational Science Spectrum.mp4\u003cbr\u003eNonneuronal Contributors to CNS Regulation of Body Weight.mp3\u003cbr\u003eNonneuronal Contributors to CNS Regulation of Body Weight.mp4\u003cbr\u003eNot All Obesity is the Same – a Look at Obesities caused by Rare Neuro-endocrine diseases.mp3\u003cbr\u003eNot All Obesity is the Same – a Look at Obesities caused by Rare Neuro-endocrine diseases.mp4\u003cbr\u003eNot Just a Consequence of Glycemic Management-The Multifaceted Harms of Treatment-Induced Hypoglycemia.mp3\u003cbr\u003eNot Just a Consequence of Glycemic Management-The Multifaceted Harms of Treatment-Induced Hypoglycemia.mp4\u003cbr\u003eNovel Insights into the Effects of Glucose-Lowering and Statin Drugs on Development of ASCVD.mp3\u003cbr\u003eNovel Insights into the Effects of Glucose-Lowering and Statin Drugs on Development of ASCVD.mp4\u003cbr\u003eNovel Nonpharmacologic Interventions to Modulate Insulin Resistance.mp3\u003cbr\u003eNovel Nonpharmacologic Interventions to Modulate Insulin Resistance.mp4\u003cbr\u003eOld Dog, New Tricks_ Making Sense of the New Research in Care Delivery.mp3\u003cbr\u003eOld Dog, New Tricks_ Making Sense of the New Research in Care Delivery.mp4\u003cbr\u003eOnce-Monthly MariTide for the Treatment of Obesity in People with or without Type 2 Diabetes-A 52-Week Phase 2 Study.mp3\u003cbr\u003eOnce-Monthly MariTide for the Treatment of Obesity in People with or without Type 2 Diabetes-A 52-Week Phase 2 Study.mp4\u003cbr\u003eOpening a Door to Precision Medicine-Lessons from Human Kidney Tissue in Diabetes.mp3\u003cbr\u003eOpening a Door to Precision Medicine-Lessons from Human Kidney Tissue in Diabetes.mp4\u003cbr\u003eOver-the-Counter Continuous Glucose Monitoring-Data for All or a Disaster Waiting to Happen_.mp3\u003cbr\u003eOver-the-Counter Continuous Glucose Monitoring-Data for All or a Disaster Waiting to Happen_.mp4\u003cbr\u003ePATHWEIGH Trial-Building the Highway for Weight Management in Primary Care.mp3\u003cbr\u003ePATHWEIGH Trial-Building the Highway for Weight Management in Primary Care.mp4\u003cbr\u003ePerspective Panel-Dropping Cost and Complications-CVD Risk and DM-SGLT2s and GLPs for CVD.mp3\u003cbr\u003ePerspective Panel-Dropping Cost and Complications-CVD Risk and DM-SGLT2s and GLPs for CVD.mp4\u003cbr\u003ePhysical Activity-Barriers, Facilitators, and Key Outcomes.mp3\u003cbr\u003ePhysical Activity-Barriers, Facilitators, and Key Outcomes.mp4\u003cbr\u003ePhysiologic Adaptations to Exercise in Diabetes.mp3\u003cbr\u003ePhysiologic Adaptations to Exercise in Diabetes.mp4\u003cbr\u003ePhysiologic Underpinnings behind New Therapies for MASLD and Diabetes.mp3\u003cbr\u003ePhysiologic Underpinnings behind New Therapies for MASLD and Diabetes.mp4\u003cbr\u003ePolygenic Scores in Research, Clinical Classification, and Prediction-Opportunities and Hurdles for Translation.mp3\u003cbr\u003ePolygenic Scores in Research, Clinical Classification, and Prediction-Opportunities and Hurdles for Translation.mp4\u003cbr\u003ePregnancy with Type 2 Diabetes-Integrating New Therapies and Technologies.mp3\u003cbr\u003ePregnancy with Type 2 Diabetes-Integrating New Therapies and Technologies.mp4\u003cbr\u003ePremiering Now – First Impressions of the twiistT AID System.mp3\u003cbr\u003ePremiering Now – First Impressions of the twiistT AID System.mp4\u003cbr\u003ePresident, Medicine \u0026amp; Science Address and Banting Medal for Scientific Achievement.mp3\u003cbr\u003ePresident, Medicine \u0026amp; Science Address and Banting Medal for Scientific Achievement.mp4\u003cbr\u003ePreventing Risk Factors for Type 2 Diabetes-Primordial Prevention of Type 2 Diabetes.mp3\u003cbr\u003ePreventing Risk Factors for Type 2 Diabetes-Primordial Prevention of Type 2 Diabetes.mp4\u003cbr\u003eProduct Theater for Zepboundr (tirzepatide) Injection.mp3\u003cbr\u003eProduct Theater for Zepboundr (tirzepatide) Injection.mp4\u003cbr\u003eProglucagon Peptide Cross Talk.mp3\u003cbr\u003eProglucagon Peptide Cross Talk.mp4\u003cbr\u003eRe-examining the Dogma of the Dietary Treatment of Non-Severe Hypoglycemia-Does the Rule of 15 Still Apply_.mp3\u003cbr\u003eRe-examining the Dogma of the Dietary Treatment of Non-Severe Hypoglycemia-Does the Rule of 15 Still Apply_.mp4\u003cbr\u003eReady for Prime Time_-Pharmacoepidemiology and Real-World Evidence.mp3\u003cbr\u003eReady for Prime Time_-Pharmacoepidemiology and Real-World Evidence.mp4\u003cbr\u003eReady, Set, Go-Outcomes of Behavioral Transition Interventions for Adolescents and Young Adults with Diabetes.mp3\u003cbr\u003eReady, Set, Go-Outcomes of Behavioral Transition Interventions for Adolescents and Young Adults with Diabetes.mp4\u003cbr\u003eReal-World Automated Insulin Delivery System Results.mp3\u003cbr\u003eReal-World Automated Insulin Delivery System Results.mp4\u003cbr\u003eRemembering Type 1 Diabetes in the Kidney Therapeutics Revolution.mp3\u003cbr\u003eRemembering Type 1 Diabetes in the Kidney Therapeutics Revolution.mp4\u003cbr\u003eRising Risks, Real Solutions-Tackling Childhood Type 2 Diabetes and Obesity.mp3\u003cbr\u003eRising Risks, Real Solutions-Tackling Childhood Type 2 Diabetes and Obesity.mp4\u003cbr\u003eSaving Kidneys and Lives Ushers in a New Era for Kidney Disease in Diabetes.mp3\u003cbr\u003eSaving Kidneys and Lives Ushers in a New Era for Kidney Disease in Diabetes.mp4\u003cbr\u003eScreen, Stage, and Manage Type 1 Diabetes_ A Proactive Approach to Care.mp3\u003cbr\u003eScreen, Stage, and Manage Type 1 Diabetes_ A Proactive Approach to Care.mp4\u003cbr\u003eScreening and Primary Prevention Strategies for ASCVD in Diabetes.mp3\u003cbr\u003eScreening and Primary Prevention Strategies for ASCVD in Diabetes.mp4\u003cbr\u003eSetting the Standard with Omnipod 5_ Remarkable Results with Unmatched Simplicity.mp3\u003cbr\u003eSetting the Standard with Omnipod 5_ Remarkable Results with Unmatched Simplicity.mp4\u003cbr\u003eShared Genetic Etiologies between Type 2 Diabetes and Related Complications and Comorbidities.mp3\u003cbr\u003eShared Genetic Etiologies between Type 2 Diabetes and Related Complications and Comorbidities.mp4\u003cbr\u003eShow Me the Data! Using Continuous Glucose Monitoring Data to Drive Behavior Change.mp3\u003cbr\u003eShow Me the Data! Using Continuous Glucose Monitoring Data to Drive Behavior Change.mp4\u003cbr\u003eSip and Chat 1.mp3\u003cbr\u003eSip and Chat 1.mp4\u003cbr\u003eSip and Chat 2.mp3\u003cbr\u003eSip and Chat 2.mp4\u003cbr\u003eSo Long Prediabetes and Its Complications!ÿ(With ADA Presidents’ Select Abstract Presentation).mp3\u003cbr\u003eSo Long Prediabetes and Its Complications!ÿ(With ADA Presidents’ Select Abstract Presentation).mp4\u003cbr\u003eSocial Driver of Health Needs (SDOH) and Cost-To Be or Not to Be_ Should We Be Incorporating Social Health Needs and Cost in Our Recommenda..mp3\u003cbr\u003eSocial Driver of Health Needs (SDOH) and Cost-To Be or Not to Be_ Should We Be Incorporating Social Health Needs and Cost in Our Recommenda..mp4\u003cbr\u003eSOUL Trial-Effects of Oral Semaglutide on Cardiovascular (and Other) Outcomes in People with Type 2 Diabetes at High CV Risk.mp3\u003cbr\u003eSOUL Trial-Effects of Oral Semaglutide on Cardiovascular (and Other) Outcomes in People with Type 2 Diabetes at High CV Risk.mp4\u003cbr\u003eStandards of Care in Diabetes 2025 Updates.mp3\u003cbr\u003eStandards of Care in Diabetes 2025 Updates.mp4\u003cbr\u003eStandards of Care in Overweight and Obesity 2025 Updates.mp3\u003cbr\u003eStandards of Care in Overweight and Obesity 2025 Updates.mp4\u003cbr\u003eStates of the Beta Cell.mp3\u003cbr\u003eStates of the Beta Cell.mp4\u003cbr\u003eStrategies for Early CKD Identification, Diagnosis, and Evidence-Based Treatment.mp3\u003cbr\u003eStrategies for Early CKD Identification, Diagnosis, and Evidence-Based Treatment.mp4\u003cbr\u003eTailoring Diabetes Education to Real-World Challenges.mp3\u003cbr\u003eTailoring Diabetes Education to Real-World Challenges.mp4\u003cbr\u003eTake Me to the River-Is Islet Blood Flow Closed and Active, or Integrated and Passive_.mp3\u003cbr\u003eTake Me to the River-Is Islet Blood Flow Closed and Active, or Integrated and Passive_.mp4\u003cbr\u003eThe Cost Chiasm-Therapeutics, Technologies, and Careÿ(With ADA Presidents’ Select Abstract Presentation).mp3\u003cbr\u003eThe Cost Chiasm-Therapeutics, Technologies, and Careÿ(With ADA Presidents’ Select Abstract Presentation).mp4\u003cbr\u003eThe Elephant in the Room-How to Address Hypertriglyceridemia in Diabetes_.mp3\u003cbr\u003eThe Elephant in the Room-How to Address Hypertriglyceridemia in Diabetes_.mp4\u003cbr\u003eThe Future of Weight Loss Therapies-Food Intake Versus Energy Expenditure.mp3\u003cbr\u003eThe Future of Weight Loss Therapies-Food Intake Versus Energy Expenditure.mp4\u003cbr\u003eThe Golden Oldies in Diabetes Management.mp3\u003cbr\u003eThe Golden Oldies in Diabetes Management.mp4\u003cbr\u003eThe Hypoglycemia Risk Profile-Leveraging Disparate Methods to Identify and Phenotype Those at Risk.mp3\u003cbr\u003eThe Hypoglycemia Risk Profile-Leveraging Disparate Methods to Identify and Phenotype Those at Risk.mp4\u003cbr\u003eThe Islet Facing Adversity-Adaptive Mechanisms.mp3\u003cbr\u003eThe Islet Facing Adversity-Adaptive Mechanisms.mp4\u003cbr\u003eThe Next Era In The Treatment Of Hypertension.mp3\u003cbr\u003eThe Next Era In The Treatment Of Hypertension.mp4\u003cbr\u003eThe Overlooked Organ-Optimizing Liver Health in Diabetes Management.mp3\u003cbr\u003eThe Overlooked Organ-Optimizing Liver Health in Diabetes Management.mp4\u003cbr\u003eThe Tidal Wave Is Coming-Heart Failure Diagnosis, Prevention, and Treatment in Patients with Type 2 Diabetes.mp3\u003cbr\u003eThe Tidal Wave Is Coming-Heart Failure Diagnosis, Prevention, and Treatment in Patients with Type 2 Diabetes.mp4\u003cbr\u003eTiming Is Everything-Circadian Rhythms in Health and Disease.mp3\u003cbr\u003eTiming Is Everything-Circadian Rhythms in Health and Disease.mp4\u003cbr\u003eTraditional and Emerging Therapeutic Methods for Lipid Management in Diabetes.mp3\u003cbr\u003eTraditional and Emerging Therapeutic Methods for Lipid Management in Diabetes.mp4\u003cbr\u003eTranscriptional and Posttranslational Mechanisms in Metabolic Control.mp3\u003cbr\u003eTranscriptional and Posttranslational Mechanisms in Metabolic Control.mp4\u003cbr\u003eTranslational and Human Studies on Metabolic Regulation.mp3\u003cbr\u003eTranslational and Human Studies on Metabolic Regulation.mp4\u003cbr\u003eTreatment of Hypercortisolism in People with Difficult-to-Control Type 2 Diabetes-Final Results of the CATALYST Trial.mp3\u003cbr\u003eTreatment of Hypercortisolism in People with Difficult-to-Control Type 2 Diabetes-Final Results of the CATALYST Trial.mp4\u003cbr\u003eTrending Topics and Smart Solutions in Pediatric Diabetes.mp3\u003cbr\u003eTrending Topics and Smart Solutions in Pediatric Diabetes.mp4\u003cbr\u003eType 2 Diabetes-From Biology to Behavior, Is It All In The Family_.mp3\u003cbr\u003eType 2 Diabetes-From Biology to Behavior, Is It All In The Family_.mp4\u003cbr\u003eUnanticipated Hot Topics in GLP-1 +_- GIP RA.mp3\u003cbr\u003eUnanticipated Hot Topics in GLP-1 +_- GIP RA.mp4\u003cbr\u003eUnder the Knife-Perioperative Considerations for Patients with Diabetic Foot Infections.mp3\u003cbr\u003eUnder the Knife-Perioperative Considerations for Patients with Diabetic Foot Infections.mp4\u003cbr\u003eUnderstanding the Type 1 Diabetes Journey_ The Importance of Early Detection.mp3\u003cbr\u003eUnderstanding the Type 1 Diabetes Journey_ The Importance of Early Detection.mp4\u003cbr\u003eUnraveling the Code-Multiomic Insights into Diabetic Foot Ulcer Healing.mp3\u003cbr\u003eUnraveling the Code-Multiomic Insights into Diabetic Foot Ulcer Healing.mp4\u003cbr\u003eUnraveling the Secrets of Energy, Appetite, and Sugar Control.mp3\u003cbr\u003eUnraveling the Secrets of Energy, Appetite, and Sugar Control.mp4\u003cbr\u003eUse of Diabetes Technology in Outpatient Pregnancy Management.mp3\u003cbr\u003eUse of Diabetes Technology in Outpatient Pregnancy Management.mp4\u003cbr\u003eUse of GLP-1RAs and SGLT2i with Automated Insulin Delivery Systems.mp3\u003cbr\u003eUse of GLP-1RAs and SGLT2i with Automated Insulin Delivery Systems.mp4\u003cbr\u003eWeight Bias.mp3\u003cbr\u003eWeight Bias.mp4\u003cbr\u003eWeight Loss in Pregnancy with Obesity-Risky Gamble or Beneficial Bet_.mp3\u003cbr\u003eWeight Loss in Pregnancy with Obesity-Risky Gamble or Beneficial Bet_.mp4\u003cbr\u003eWelcome to the 85th ADA Scientific Sessions \u0026amp; ‘Pathway to Stop Diabetes’.mp3\u003cbr\u003eWelcome to the 85th ADA Scientific Sessions \u0026amp; ‘Pathway to Stop Diabetes’.mp4\u003cbr\u003eWhat Is the Best Way to Measure the Burden and Severity of Hypoglycemia in People Living with Diabetes_.mp3\u003cbr\u003eWhat Is the Best Way to Measure the Burden and Severity of Hypoglycemia in People Living with Diabetes_.mp4\u003cbr\u003eWhat Is the Real Molecular Target(s) of Metformin_.mp3\u003cbr\u003eWhat Is the Real Molecular Target(s) of Metformin_.mp4\u003cbr\u003eWhat’s New with Automated Insulin Delivery_.mp3\u003cbr\u003eWhat’s New with Automated Insulin Delivery_.mp4\u003cbr\u003eWhat’s New with Continuous Glucose Monitoring_.mp3\u003cbr\u003eWhat’s New with Continuous Glucose Monitoring_.mp4\u003cbr\u003eWhat’s New with Interpretation of CGM Metrics and Relationship to A1C, eA1C and GMI_.mp3\u003cbr\u003eWhat’s New with Interpretation of CGM Metrics and Relationship to A1C, eA1C and GMI_.mp4\u003cbr\u003eWhen the Treatment of Type 2 Diabetes Becomes Nuanced.mp3\u003cbr\u003eWhen the Treatment of Type 2 Diabetes Becomes Nuanced.mp4","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954500112482,"sku":"MED-AMB04715","price":75.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/ADA-85th-Scientific-Sessions.png?v=1779378179","url":"https:\/\/meducourse.com\/products\/ada-85th-scientific-sessions","provider":"Meducourse","version":"1.0","type":"link"}